Benjamin P. Linas, MD

Associate Professor, Medicine

Benjamin Linas
617.414.5238

Biography

Dr. Linas is a national leader in hepatitis-C virus (HCV) infection and HCV/HIV co-infection comparative- and cost-effectiveness research using computational biology, clinical epidemiology and clinical economics methods. Dr. Linas has an excellent track record of productivity, ample funding from the NIH and CDC, and a growing core of successful trainees. Dr. Linas directs the HIV/HCV core of the Center for Health Economics of Treatment Interventions for Substance Use Disorders, HCV, and HIV, funded by the National Institute on Drug Abuse (NIDA) in collaboration with Cornell, U Penn and Miami.

Other Positions

  • Associate Professor, Epidemiology, Boston University School of Public Health

Education

  • New York University School of Medicine, MD
  • Harvard School of Public Health, MPH
  • Yale University, BA

Publications

  • Published on 1/1/2019

    Tasillo A, Linas BP. Decision Science at Work: The Case of Latent Tuberculosis Screening. Am J Kidney Dis. 2019 Jan; 73(1):8-10. PMID: 30579384.

    Read at: PubMed
  • Published on 12/27/2018

    Shelton BA, Berdahl G, Sawinski D, Linas BP, Reese PP, Mustian MN, Reed RD, MacLennan PA, Locke JE. Optimal Timing of Hepatitis C Treatment among HIV/HCV Co-infected ESRD Patients: Pre vs. Post-Transplant. Am J Transplant. 2018 Dec 27. PMID: 30589503.

    Read at: PubMed
  • Published on 11/28/2018

    Leech AA, Burgess JF, Sullivan M, Kuohung W, HornĂ½ M, Drainoni ML, Christiansen CL, Linas BP. Cost-effectiveness of preexposure prophylaxis for HIV prevention for conception in the United States. AIDS. 2018 Nov 28; 32(18):2787-2798. PMID: 30234602.

    Read at: PubMed
  • Published on 11/19/2018

    Assoumou SA, Wang J, Tasillo A, Eftekhari Yazdi G, Tsui JI, Strick L, Linas BP. Hepatitis C Testing and Patient Characteristics in Washington State's Prisons Between 2012 and 2016. Am J Prev Med. 2019 Jan; 56(1):8-16. PMID: 30467088.

    Read at: PubMed
  • Published on 10/25/2018

    Barocas JA, White LF, Wang J, Walley AY, LaRochelle MR, Bernson D, Land T, Morgan JR, Samet JH, Linas BP. Estimated Prevalence of Opioid Use Disorder in Massachusetts, 2011-2015: A Capture-Recapture Analysis. Am J Public Health. 2018 Dec; 108(12):1675-1681. PMID: 30359112.

    Read at: PubMed
  • Published on 8/30/2018

    Shelton BA, Sawinski D, Linas BP, Reese PP, Mustian M, Hungerpiller M, Reed RD, MacLennan PA, Locke JE. Population level outcomes and cost-effectiveness of hepatitis C treatment pre- vs postkidney transplantation. Am J Transplant. 2018 Oct; 18(10):2483-2495. PMID: 30058218.

    Read at: PubMed
  • Published on 8/28/2018

    Epstein RL, Sabharwal V, Wachman EM, Saia KA, Vellozzi C, Hariri S, Linas BP. Perinatal Transmission of Hepatitis C Virus: Defining the Cascade of Care. J Pediatr. 2018 Dec; 203:34-40.e1. PMID: 30170857.

    Read at: PubMed
  • Published on 8/1/2018

    Wurcel AG, Burke DJ, Wang JJ, Engle B, Noonan K, Knox TA, Kim AY, Linas BP. The Burden of Untreated HCV Infection in Hospitalized Inmates: a Hospital Utilization and Cost Analysis. J Urban Health. 2018 Aug; 95(4):467-473. PMID: 30027427.

    Read at: PubMed
  • Published on 8/1/2018

    Barocas JA, Tasillo A, Eftekhari Yazdi G, Wang J, Vellozzi C, Hariri S, Isenhour C, Randall L, Ward JW, Mermin J, Salomon JA, Linas BP. Population-level Outcomes and Cost-Effectiveness of Expanding the Recommendation for Age-based Hepatitis C Testing in the United States. Clin Infect Dis. 2018 Aug 01; 67(4):549-556. PMID: 29420742.

    Read at: PubMed
  • Published on 7/1/2018

    Linas BP. Commentary on Bansback et al. (2018): Estimating the cost of stigma against injection. Addiction. 2018 Jul; 113(7):1274-1275. PMID: 29883035.

    Read at: PubMed

View 64 more publications: View full profile at BUMC

View all profiles